New American heart association/American college of cardiology guidelines on cardiovascular risk: When will fitness get the recognition it deserves?

Mayo Clinic Proceedings

Volumn 89, Issue 6, 2014, Pages 722-726

  Myers, Jonathan ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DRUG COST; EXERCISE; FITNESS; HEALTH CARE COST; HEALTH PROMOTION; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; LIFESTYLE MODIFICATION; NOTE; PHYSICAL ACTIVITY; PHYSICAL INACTIVITY; PRACTICE GUIDELINE; PRIMARY PREVENTION; RISK ASSESSMENT; SECONDARY PREVENTION;

CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE;

EID: 84904730544     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2014.03.002     Document Type: Short Survey

References (34)

1. Goff DC, Lloyd-Jones DM, Bennett G, et al. ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [published ahead of print November 12, 2013]. Circulation. http://dx.doi.org/10. 1161/01.cir.0000437741.48606.98.
2. Stone NL, Robinson J, Lichtenstein AH, et al. 2013 AHA/ACC Guidelines on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the ACC/AHA Task Force on Practice Guidelines [published ahead of print November 12, 2013]. Circulation. http://dx.doi.org/10.1161/01. cir.0004437738.63853.7a.
3. Abramson JD, Redberg RF. Don't give more patients statins. New York Times. November 13, 2013. http://www.nytimes.com/2013/11/14/opinion/dont-give- more-patients-statins.html?-r=0. Accessed December 18, 2013.
4. Taylor F, Huffman MD, Macedo AF, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013;(1):CD004816. http://dx.doi.org/10.1002/14651858.CD004816.pub5.
5. Pharmacy Checker. Zocor pricing and ordering comparisons. https://www.pharmacychecker.com/compare-drug-prices-onlinepharmacies/ zocor-20+mg/19487/31766. Accessed December 16, 2013.
6. Ridker PM, Cook NR. Statins: New American guidelines for prevention of cardiovascular disease. Lancet. 2013;382(9907): 1762-1765.
7. Fletcher GF, Blair SN, Blumenthal J, et al. Statement on exercise: benefits and recommendations for physical activity programs for all Americans: A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart Association. Circulation. 1992;86(1):340-344.
8. VanWormer JJ, Pronk NP, Kroeninger GJ. Clinical counseling for physical activity: translation of a systematic review into care recommendations. Diabetes Spectrum. 2009;22(1):49-55.
9. Myers J. Physical activity: the missing prescription. Eur J Cardiovasc Prev Rehabil. 2005;12(2):85-86.
10. Kodama S, Saito K, Tanaka S, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA. 2009; 301(19):2024-2035.
11. Arena R, Myers J, Guazzi M. The future of aerobic exercise testing in clinical practice: Is it the ultimate vital sign? Future Cardiol. 2010;6(3):325-342.
12. Mark DB, Lauer MS. Exercise capacity: the prognostic variable that doesn't get enough respect. Circulation. 2003;108(13):1534-1536.
13. Blair SN. Physical inactivity: the biggest health problem of the 21st century. Br J Sports Med. 2009;43(1):1-2.
14. Franklin BA. Physical activity to combat chronic diseases and escalating health care costs: the unfilled prescription. Curr Sports Med Rep. 2008;7(3):122-125.
15. Gutierrez J, Ramirez G, Rundek T, Sacco RL. Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis. Arch Intern Med. 2012;172(12):909-919.
16. Kostis WJ, Cheng JQ, Dobrzynski JM, Cabrera J, Kostis JB. Metaanalysis of statin effects in women versus men. J Am Coll Cardiol. 2012;59(6):572-582.
17. Abramson JD, Rosenberg HG. Should people at low risk of cardiovascular disease take a statin? BMJ. 2013;347:f6123. http://dx.doi.org/10.1136/bmj.f6123.
18. Ridker RM. The Jupiter Trial: results, controversies, and implications for prevention. Circ Cardiovasc Qual Outcomes. 2009; 2(3):279-285.
19. Thompson A, Temple NJ. The case for statins: has it really been made? J R Soc Med. 2004;97(10):461-464.
20. Ornish D. Statins and the soul of medicine. 2002;89(11): 1286-1290.
21. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med. 2000;343(1):16-22.
22. Yusuf S, Hawken S, Ounpuu S, et al; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937-952.
23. World Health Organization. Unhealthy Diets and Physical Inactivity. http://www.who.int/nmh/publications/fact-sheet-diet-en.pdf. Accessed December 20, 2013.
24. Nocon M, Hiemann T, Müller-Riemenschneider F, Thalau F, Roll S, Willich SN. Association of physical activity with all-cause and cardiovascular mortality: a systematic review and metaanalysis. Eur J Cardiovasc Prev Rehabil. 2008;15(3):239-246.
25. Naci H, Ioannidis JPA. Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study. BMJ. 2013;347:f5577. http://dx.doi.org/10.1136/bmj.f5577.
26. Kokkinos P, Myers J, Faselis C, Panagiotakos D, Doumas M. Interactive effects of fitness and statin treatment on mortality risk in veterans with dyslipidemia: a cohort study. Lancet. 2012; 381(9864):394-399.
27. Ward S, Lloyd Jones M, Pandor A, et al. A systematic review and economic evaluation of statins for the prevention of coronary events. Health Technol Assess. 2007;11(14):1-160:iii-iv.
28. McConnachie A, Walker A, Robertson M, et al. Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: a record linkage study. Eur Heart J. 2014;35(5): 290-298. http://dx.doi.org/10.1093/eurheartj/eht232.
29. Arena R, Guazzi M, Briggs P, et al. Promoting health and wellness in the workplace: a unique opportunity to establish primary and secondary prevention cardiac rehabilitation programs. Mayo Clinic Proc. 2013;88(6):605-617.
30. Goetzel RZ, Ozminkowski RJ. The health and cost benefits of work site health-promotion programs. Annu Rev Public Health. 2008;29:303-323.
31. Pronk NP, Goodman MJ, O'Connor PJ, Martinson BC. Relationship between modifiable health risks and short-term health care charges. JAMA. 1999;282(23):2235-2239.
32. Ghayoumi A, Myers J, Abella J, et al. Physical activity patterns and health care costs [abstract]. J Am Coll Cardiol. 2004;45:16A.
33. Bachman JM, Willis BL, DeFina LF, Gao A, Leonard DS, Berry JD. Association of midlife fitness with healthcare charges in later life: The Cooper Center Longitudinal Study [abstract]. Circ Cardiovasc Qual Outcomes. 2012;5:A191.
34. Weiss P, Froelicher V, Myers J, Heidenreich P. Health care costs and exercise capacity. Chest. 2004;126(2):608-613.